Abstract
Insulin resistance, a common feature of metabolic disorders such as obesity, nonalcoholic fatty liver disease, metabolic syndrome, and polycystic ovary syndrome, is a risk factor for development of diabetes. Because sex hormones orchestrate the establishment of sex-specific behavioral, reproductive, and metabolic differences, a role for them in the developmental origin of insulin resistance is also to be expected. Female sheep exposed to male levels of testosterone during fetal life serve as an excellent translational model for delineating programming of insulin resistance. This chapter summarizes the ontogeny of insulin resistance, the tissue-specific changes in insulin sensitivity, and the various factors that are involved in the programming and maintenance of the insulin resistance in adult female sheep that were developmentally exposed to fetal male levels of testosterone during the sexual-differentiation window.
References
Abbott, D. H., Nicol, L. E., Levine, J. E., Xu, N., Goodarzi, M. O., & Dumesic, D. A. (2013). Nonhuman primate models of polycystic ovary syndrome. Molecular and Cellular Endocrinology, 373(1ā2), 21ā28. https://doi.org/10.1016/j.mce.2013.01.013.
Abel, E. D. (2004). Glucose transport in the heart. Frontiers in Bioscience, 9, 201ā215.
Achari, A. E., & Jain, S. K. (2017). Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction. International Journal of Molecular Sciences, 18(6). https://doi.org/10.3390/ijms18061321.
Aguilar, M., Bhuket, T., Torres, S., Liu, B., & Wong, R. J. (2015). Prevalence of the metabolic syndrome in the United States, 2003ā2012. JAMA, 313(19), 1973ā1974. https://doi.org/10.1001/jama.2015.4260.
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., Witchel, S. F., & Androgen Excess, S. (2006). Positions statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline. The Journal of Clinical Endocrinology and Metabolism, 91(11), 4237ā4245. https://doi.org/10.1210/jc.2006-0178.
Barker, D. J. (2004). The developmental origins of adult disease. Journal of the American College of Nutrition, 23(6 Suppl), 588Sā595S.
Barry, J. S., & Anthony, R. V. (2008). The pregnant sheep as a model for human pregnancy. Theriogenology, 69(1), 55ā67. https://doi.org/10.1016/j.theriogenology.2007.09.021.
Bashan, N., Kovsan, J., Kachko, I., Ovadia, H., & Rudich, A. (2009). Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiological Reviews, 89(1), 27ā71. https://doi.org/10.1152/physrev.00014.2008.
Beck-Peccoz, P., Padmanabhan, V., Baggiani, A. M., Cortelazzi, D., Buscaglia, M., Medri, G., Marconi, A. M., Pardi, G., & Beitins, I. Z. (1991). Maturation of hypothalamic-pituitary-gonadal function in normal human fetuses: Circulating levels of gonadotropins, their common alpha-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone. The Journal of Clinical Endocrinology and Metabolism, 73(3), 525ā532. https://doi.org/10.1210/jcem-73-3-525.
Boonyaratanakornkit, V., & Pateetin, P. (2015). The role of ovarian sex steroids in metabolic homeostasis, obesity, and postmenopausal breast cancer: Molecular mechanisms and therapeutic implications. BioMed Research International, 2015, 140196. https://doi.org/10.1155/2015/140196.
Bramble, M. S., Roach, L., Lipson, A., Vashist, N., Eskin, A., Ngun, T., Gosschalk, J. E., Klein, S., Barseghyan, H., Arboleda, V. A., & Vilain, E. (2016). Sex-specific effects of testosterone on the sexually dimorphic transcriptome and epigenome of embryonic neural stem/progenitor cells. Scientific Reports, 6, 36916. https://doi.org/10.1038/srep36916.
Brons, C., & Grunnet, L. G. (2017). Mechanisms in Endocrinology: Skeletal muscle lipotoxicity in insulin resistance and type 2 diabetes: a causal mechanism or an innocent bystander? European Journal of Endocrinology/European Federation of Endocrine Societies, 176(2), R67āR78. https://doi.org/10.1530/EJE-16-0488.
Cardoso, R. C., Puttabyatappa, M., & Padmanabhan, V. (2015). Steroidogenic versus metabolic programming of reproductive neuroendocrine, ovarian and metabolic dysfunctions. Neuroendocrinology, 102(3), 226ā237. https://doi.org/10.1159/000381830.
Cardoso, R. C., Veiga-Lopez, A., Moeller, J., Beckett, E., Pease, A., Keller, E., Madrigal, V., Chazenbalk, G., Dumesic, D., & Padmanabhan, V. (2016). Developmental programming: Impact of gestational steroid and metabolic milieus on adiposity and insulin sensitivity in prenatal testosterone-treated female sheep. Endocrinology, 157(2), 522ā535. https://doi.org/10.1210/en.2015-1565.
Caselli, C. (2014). Role of adiponectin system in insulin resistance. Molecular Genetics and Metabolism, 113(3), 155ā160. https://doi.org/10.1016/j.ymgme.2014.09.003.
Clarke, I. J. (1992). What can we learn from sampling hypophysial portal blood? Ciba Foundation Symposium, 168, 87ā95. discussion 95ā103.
Crespi, E. J., Steckler, T. L., Mohankumar, P. S., & Padmanabhan, V. (2006). Prenatal exposure to excess testosterone modifies the developmental trajectory of the insulin-like growth factor system in female sheep. The Journal of Physiology, 572(Pt 1), 119ā130. https://doi.org/10.1113/jphysiol.2005.103929.
Deeming, D. C., & Ferguson, M. W. J. (1989). The mechanism of temperature dependent sex determination in crocodilians: A hypothesis1. American Zoologist, 29(3), 973ā985. https://doi.org/10.1093/icb/29.3.973.
Dimitriadis, G., Mitrou, P., Lambadiari, V., Maratou, E., & Raptis, S. A. (2011). Insulin effects in muscle and adipose tissue. Diabetes Research and Clinical Practice, 93(Suppl 1), S52āS59. https://doi.org/10.1016/S0168-8227(11)70014-6.
Ertunc, M. E., & Hotamisligil, G. S. (2016). Lipid signaling and lipotoxicity in metaflammation: Indications for metabolic disease pathogenesis and treatment. Journal of Lipid Research, 57(12), 2099ā2114. https://doi.org/10.1194/jlr.R066514.
Esser, N., Legrand-Poels, S., Piette, J., Scheen, A. J., & Paquot, N. (2014). Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Research and Clinical Practice, 105(2), 141ā150. https://doi.org/10.1016/j.diabres.2014.04.006.
Flegal, K. M., Kruszon-Moran, D., Carroll, M. D., Fryar, C. D., & Ogden, C. L. (2016). Trends in obesity among adults in the United States, 2005 to 2014. JAMA, 315(21), 2284ā2291. https://doi.org/10.1001/jama.2016.6458.
Fu, Y. (2014). Adiponectin signaling and metabolic syndrome. Progress in Molecular Biology and Translational Science, 121, 293ā319. https://doi.org/10.1016/B978-0-12-800101-1.00009-0.
Hanson, M., & Gluckman, P. (2011). Developmental origins of noncommunicable disease: Population and public health implications. The American Journal of Clinical Nutrition, 94(6 Suppl), 1754Sā1758S. https://doi.org/10.3945/ajcn.110.001206.
Hogg, K., Wood, C., McNeilly, A. S., & Duncan, W. C. (2011). The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. PLoS One, 6(9), e24877. https://doi.org/10.1371/journal.pone.0024877.
Jones, H., Sprung, V. S., Pugh, C. J., Daousi, C., Irwin, A., Aziz, N., Adams, V. L., Thomas, E. L., Bell, J. D., Kemp, G. J., & Cuthbertson, D. J. (2012). Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. The Journal of Clinical Endocrinology and Metabolism, 97(10), 3709ā3716. https://doi.org/10.1210/jc.2012-1382.
Jost, A. (1983). Genetic and hormonal factors in sex differentiation of the brain. Psychoneuroendocrinology, 8(2), 183ā193.
Kadowaki, T., & Yamauchi, T. (2005). Adiponectin and adiponectin receptors. Endocrine Reviews, 26(3), 439ā451. https://doi.org/10.1210/er.2005-0005.
Kahn, B. B., & Flier, J. S. (2000). Obesity and insulin resistance. The Journal of Clinical Investigation, 106(4), 473ā481. https://doi.org/10.1172/JCI10842.
King, A. J., Olivier, N. B., Mohankumar, P. S., Lee, J. S., Padmanabhan, V., & Fink, G. D. (2007). Hypertension caused by prenatal testosterone excess in female sheep. American Journal of Physiology Endocrinology and Metabolism, 292(6), E1837āE1841. https://doi.org/10.1152/ajpendo.00668.2006.
Liu, Y., & Sweeney, G. (2014). Adiponectin action in skeletal muscle. Best Practice & Research Clinical Endocrinology & Metabolism, 28(1), 33ā41. https://doi.org/10.1016/j.beem.2013.08.003.
Liu, W., Baker, R. D., Bhatia, T., Zhu, L., & Baker, S. S. (2016). Pathogenesis of nonalcoholic steatohepatitis. Cellular and Molecular Life Sciences, 73(10), 1969ā1987. https://doi.org/10.1007/s00018-016-2161-x.
Livingstone, C., & Collison, M. (2002). Sex steroids and insulin resistance. Clinical Science (London, England), 102(2), 151ā166.
Lu, C., Cardoso, R. C., Puttabyatappa, M., & Padmanabhan, V. (2016). Developmental programming: Prenatal testosterone excess and insulin signaling disruptions in female sheep. Biology of Reproduction, 94(5), 113. https://doi.org/10.1095/biolreprod.115.136283.
Lucas, A. (1991). Programming by early nutrition in man. Ciba Foundation Symposium, 156, 38ā50. discussion 50ā35.
Macut, D., Bjekic-Macut, J., & Savic-Radojevic, A. (2013). Dyslipidemia and oxidative stress in PCOS. Frontiers of Hormone Research, 40, 51ā63. https://doi.org/10.1159/000341683.
Manikkam, M., Crespi, E. J., Doop, D. D., Herkimer, C., Lee, J. S., Yu, S., Brown, M. B., Foster, D. L., & Padmanabhan, V. (2004). Fetal programming: Prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology, 145(2), 790ā798. https://doi.org/10.1210/en.2003-0478.
Mauvais-Jarvis, F. (2015). Sex differences in metabolic homeostasis, diabetes, and obesity. Biology of Sex Differences, 6, 14. https://doi.org/10.1186/s13293-015-0033-y.
Meisel, R. L., & Ward, I. L. (1981). Fetal female rats are masculinized by male littermates located caudally in the uterus. Science, 213(4504), 239ā242.
Melo, A. S., Vieira, C. S., Barbieri, M. A., Rosa, E. S. A. C., Silva, A. A., Cardoso, V. C., Reis, R. M., Ferriani, R. A., Silva-de-Sa, M. F., & Bettiol, H. (2010). High prevalence of polycystic ovary syndrome in women born small for gestational age. Human Reproduction, 25(8), 2124ā2131. https://doi.org/10.1093/humrep/deq162.
Menke, A., Casagrande, S., Geiss, L., & Cowie, C. C. (2015). Prevalence of and trends in diabetes among adults in the United States, 1988ā2012. JAMA, 314(10), 1021ā1029. https://doi.org/10.1001/jama.2015.10029.
Moran, L. J., Norman, R. J., & Teede, H. J. (2015). Metabolic risk in PCOS: Phenotype and adiposity impact. Trends in Endocrinology and Metabolism, 26(3), 136ā143. https://doi.org/10.1016/j.tem.2014.12.003.
Morishima, A., Grumbach, M. M., Simpson, E. R., Fisher, C., & Qin, K. (1995). Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. The Journal of Clinical Endocrinology and Metabolism, 80(12), 3689ā3698. https://doi.org/10.1210/jcem.80.12.8530621.
Morrison, J. L., Duffield, J. A., Muhlhausler, B. S., Gentili, S., & McMillen, I. C. (2010). Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity. Pediatric Nephrology, 25(4), 669ā677. https://doi.org/10.1007/s00467-009-1407-3.
Nada, S. E., Thompson, R. C., & Padmanabhan, V. (2010). Developmental programming: Differential effects of prenatal testosterone excess on insulin target tissues. Endocrinology, 151(11), 5165ā5173. https://doi.org/10.1210/en.2010-0666.
Nijland, M. J., Ford, S. P., & Nathanielsz, P. W. (2008). Prenatal origins of adult disease. Current Opinion in Obstetrics & Gynecology, 20(2), 132ā138. https://doi.org/10.1097/GCO.0b013e3282f76753.
Nikoulina, S. E., Ciaraldi, T. P., Mudaliar, S., Mohideen, P., Carter, L., & Henry, R. R. (2000). Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes, 49(2), 263ā271.
Nuutila, P., Knuuti, M. J., Maki, M., Laine, H., Ruotsalainen, U., Teras, M., Haaparanta, M., Solin, O., & Yki-Jarvinen, H. (1995). Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes, 44(1), 31ā36.
Ohlsson, C., Hellberg, N., Parini, P., Vidal, O., Bohlooly, Y. M., Rudling, M., Lindberg, M. K., Warner, M., Angelin, B., & Gustafsson, J. A. (2000). Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochemical and Biophysical Research Communications, 278(3), 640ā645. https://doi.org/10.1006/bbrc.2000.3827.
Padmanabhan, V., & Veiga-Lopez, A. (2013). Sheep models of polycystic ovary syndrome phenotype. Molecular and Cellular Endocrinology, 373(1ā2), 8ā20. https://doi.org/10.1016/j.mce.2012.10.005.
Padmanabhan, V., & Veiga-Lopez, A. (2014). Reproduction symposium: Developmental programming of reproductive and metabolic health. Journal of Animal Science, 92(8), 3199ā3210. https://doi.org/10.2527/jas.2014-7637.
Padmanabhan, V., Veiga-Lopez, A., Abbott, D., Recabarren, S., & Herkimer, C. (2010). Developmental programming: Impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females. Endocrinology, 151(2), 595ā605.
Padmanabhan, V., Cardoso, R. C., & Puttabyatappa, M. (2016). Developmental programming, a pathway to disease. Endocrinology, 157(4), 1328ā1340. https://doi.org/10.1210/en.2016-1003.
Pradhan, A. D. (2014). Sex differences in the metabolic syndrome: Implications for cardiovascular health in women. Clinical Chemistry, 60(1), 44ā52. https://doi.org/10.1373/clinchem.2013.202549.
Puttabyatappa, M., Andriessen, V., Mesquitta, M., Zeng, L., Pennathur, S., & Padmanabhan, V. (2017). Developmental programming: Impact of gestational steroid and metabolic milieus on mediators of insulin sensitivity in prenatal testosterone-treated female sheep. Endocrinology, 158(9), 2783ā2798.Ā https://doi.org/10.1210/en.2017-00460.
Rae, M., Grace, C., Hogg, K., Wilson, L. M., McHaffie, S. L., Ramaswamy, S., MacCallum, J., Connolly, F., McNeilly, A. S., & Duncan, C. (2013). The pancreas is altered by in utero androgen exposure: Implications for clinical conditions such as polycystic ovary syndrome (PCOS). PLoS One, 8(2), e56263. https://doi.org/10.1371/journal.pone.0056263.
Ramaswamy, S., Grace, C., Mattei, A. A., Siemienowicz, K., Brownlee, W., MacCallum, J., McNeilly, A. S., Duncan, W. C., & Rae, M. T. (2016). Developmental programming of polycystic ovary syndrome (PCOS): Prenatal androgens establish pancreatic islet alpha/beta cell ratio and subsequent insulin secretion. Scientific Reports, 6, 27408. https://doi.org/10.1038/srep27408.
Rani, V., Deep, G., Singh, R. K., Palle, K., & Yadav, U. C. (2016). Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies. Life Sciences, 148, 183ā193. https://doi.org/10.1016/j.lfs.2016.02.002.
Rao, P. M., Kelly, D. M., & Jones, T. H. (2013). Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nature Reviews Endocrinology, 9(8), 479ā493. https://doi.org/10.1038/nrendo.2013.122.
Rask-Madsen, C., & Kahn, C. R. (2012). Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(9), 2052ā2059. https://doi.org/10.1161/ATVBAHA.111.241919.
Recabarren, S. E., Padmanabhan, V., Codner, E., Lobos, A., DurĆ”n, C., Vidal, M., Foster, D. L., & Sir-Petermann, T. (2005). Postnatal developmental consequences of altered insulin sensitivity in female sheep treated prenatally with testosterone. American Journal of Physiology-Endocrinology and Metabolism, 289(5), E801āE806.
Rochlani, Y., Pothineni, N. V., & Mehta, J. L. (2015). Metabolic syndrome: Does it differ between women and men? Cardiovascular Drugs and Therapy, 29(4), 329ā338. https://doi.org/10.1007/s10557-015-6593-6.
Romeo, G. R., Lee, J., & Shoelson, S. E. (2012). Metabolic syndrome, insulin resistance, and roles of inflammationĀ ā mechanisms and therapeutic targets. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(8), 1771ā1776. https://doi.org/10.1161/ATVBAHA.111.241869.
Ropero, A. B., Alonso-Magdalena, P., Quesada, I., & Nadal, A. (2008). The role of estrogen receptors in the control of energy and glucose homeostasis. Steroids, 73(9ā10), 874ā879. https://doi.org/10.1016/j.steroids.2007.12.018.
Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19(1), 41ā47. https://doi.org/10.1093/humrep/deh098.
Ruan, H., & Dong, L. Q. (2016). Adiponectin signaling and function in insulin target tissues. Journal of Molecular Cell Biology, 8(2), 101ā109. https://doi.org/10.1093/jmcb/mjw014.
Saltiel, A. R., & Kahn, C. R. (2001). Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 414(6865), 799ā806. https://doi.org/10.1038/414799a.
Savkur, R. S., Philips, A. V., & Cooper, T. A. (2001). Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nature Genetics, 29(1), 40ā47. https://doi.org/10.1038/ng704.
Sayiner, M., Koenig, A., Henry, L., & Younossi, Z. M. (2016). Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world. Clinics in Liver Disease, 20(2), 205ā214. https://doi.org/10.1016/j.cld.2015.10.001.
Sir-Petermann, T., Hitchsfeld, C., Maliqueo, M., Codner, E., Echiburu, B., Gazitua, R., Recabarren, S., & Cassorla, F. (2005). Birth weight in offspring of mothers with polycystic ovarian syndrome. Human Reproduction, 20(8), 2122ā2126. https://doi.org/10.1093/humrep/dei009.
Sir-Petermann, T., Ladron de Guevara, A., Villarroel, A. C., Preisler, J., Echiburu, B., & Recabarren, S. (2012). Polycystic ovary syndrome and pregnancy. Revista MĆ©dica de Chile, 140(7), 919ā925. https://doi.org/10.4067/S0034-98872012000700015.
Soumaya, K. (2012). Molecular mechanisms of insulin resistance in diabetes. Advances in Experimental Medicine and Biology, 771, 240ā251.
Steckler, T., Wang, J., Bartol, F. F., Roy, S. K., & Padmanabhan, V. (2005). Fetal programming: Prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment. Endocrinology, 146(7), 3185ā3193.
Tang, W. Y., & Ho, S. M. (2007). Epigenetic reprogramming and imprinting in origins of disease. Reviews in Endocrine & Metabolic Disorders, 8(2), 173ā182. https://doi.org/10.1007/s11154-007-9042-4.
Veiga-Lopez, A., Steckler, T. L., Abbott, D. H., Welch, K. B., MohanKumar, P. S., Phillips, D. J., Refsal, K., & Padmanabhan, V. (2011). Developmental programming: Impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep. Biology of Reproduction, 84(1), 87ā96. https://doi.org/10.1095/biolreprod.110.086686.
Veiga-Lopez, A., Moeller, J., Patel, D., Ye, W., Pease, A., Kinns, J., & Padmanabhan, V. (2013). Developmental programming: Impact of prenatal testosterone excess on insulin sensitivity, adiposity, and free fatty acid profile in postpubertal female sheep. Endocrinology, 154(5), 1731ā1742. https://doi.org/10.1210/en.2012-2145.
Verdile, G., Keane, K. N., Cruzat, V. F., Medic, S., Sabale, M., Rowles, J., Wijesekara, N., Martins, R. N., Fraser, P. E., & Newsholme, P. (2015). Inflammation and oxidative stress: The molecular connectivity between insulin resistance, obesity, and Alzheimerās disease. Mediators of Inflammation, 2015, 105828. https://doi.org/10.1155/2015/105828.
Villa, J., & Pratley, R. E. (2011). Adipose tissue dysfunction in polycystic ovary syndrome. Current Diabetes Reports, 11(3), 179ā184. https://doi.org/10.1007/s11892-011-0189-8.
Vom Saal, F. S. (2016). Triennial reproduction symposium: Environmental programming of reproduction during fetal life: Effects of intrauterine position and the endocrine disrupting chemical bisphenol A. Journal of Animal Science, 94(7), 2722ā2736. https://doi.org/10.2527/jas.2015-0211.
Vyas, A. K., Hoang, V., Padmanabhan, V., Gilbreath, E., & Mietelka, K. A. (2016). Prenatal programming: Adverse cardiac programming by gestational testosterone excess. Scientific Reports, 6, 28335. https://doi.org/10.1038/srep28335.
Wallace, I. R., McKinley, M. C., Bell, P. M., & Hunter, S. J. (2013). Sex hormone binding globulin and insulin resistance. Clinical Endocrinology, 78(3), 321ā329. https://doi.org/10.1111/cen.12086.
Zawadzki, J., & Dunaif, A. (1992). Current issues in endocrinology and metabolism: Polycystic ovary syndrome. Cambridge, MA: Blackwell Scientific Publications.
Funding Support
This work was supported by NIH P01 HD44232.
Disclosure Statement
The authors have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Puttabyatappa, M., Padmanabhan, V. (2017). Prenatal Testosterone Programming of Insulin Resistance in theĀ Female Sheep. In: Mauvais-Jarvis, F. (eds) Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity. Advances in Experimental Medicine and Biology, vol 1043. Springer, Cham. https://doi.org/10.1007/978-3-319-70178-3_25
Download citation
DOI: https://doi.org/10.1007/978-3-319-70178-3_25
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-70177-6
Online ISBN: 978-3-319-70178-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)